𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

✍ Scribed by Per E. Lønning; Paul D. Taylor; Gun Anker; Julie Iddon; Liv Wie; Linn-Marie Jørgensen; Olav Mella; Anthony Howell

Book ID
110292567
Publisher
Springer US
Year
2001
Tongue
English
Weight
65 KB
Volume
67
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 randomized trial of primary endo
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/

Histochemical assay of estrogen and prog
Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients' response to endocrine therapies
✍ Louis P. Pertschuk; Ellis H. Tobin; Eric Gaetjens; Anne C. Carter; George A. Deg 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand-conjugates composed of 17P-estradiol and 1 lcu-hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescein isothiocyanate were emp